Cargando…
COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819197/ https://www.ncbi.nlm.nih.gov/pubmed/35129668 http://dx.doi.org/10.1007/s00431-022-04390-2 |
_version_ | 1784646005112700928 |
---|---|
author | Yilmaz Ciftdogan, Dilek Ekemen Keles, Yildiz Cetin, Benhur Sirvan Dalgic Karabulut, Nazan Emiroglu, Melike Bagci, Zafer Buyukcam, Ayse Erdeniz, Emine Hafize Arga, Gul Yesil, Edanur Cakici, Ozlem Karbuz, Adem Sahbudak Bal, Zumrut Kara, Soner Sertan Ozer, Arife Metin Akcan, Ozge Elmas Bozdemir, Sefika Anil, Ayse Berna Uygun, Hatice Kilic, Omer Hancerli Torun, Selda Umit, Zuhal Sutcu, Murat Ozgokce Ozmen, Berfin Karaoglu Asrak, Hatice Alkan, Gulsum Kara Aksay, Ahu Ugur, Cuneyt Birbilen, Ahmet Ziya Bursal Duramaz, Burcu Akyuz Ozkan, Esra Burakay, Ozgur Yildirim Arslan, Sema Karadag Oncel, Eda Celik, Serkan Fazli Kilic, Ahmet Osman Ozen, Seval Sarikaya, Remzi Demirkol, Demet Arslan, Gazi Turel, Ozden Sert, Ahmet Sari, Ergul Orbak, Zerrin Sahin, Irfan Oguz Varan, Celal Akturk, Hacer Tuter Oz, Sadiye Kubra Durak, Fatih Oflaz, Mehmet Burhan Kara, Manolya Karpuz, Derya Talip Petmezci, Mey Hatipoglu, Nevin Oncel, Selim Turgut, Mehmet Elmali, Ferhan Somer, Ayper Kuyucu, Necdet Dinleyici, Ener Cagri Kurugöl, Zafer Ciftci, Ergin Kara, Ates |
author_facet | Yilmaz Ciftdogan, Dilek Ekemen Keles, Yildiz Cetin, Benhur Sirvan Dalgic Karabulut, Nazan Emiroglu, Melike Bagci, Zafer Buyukcam, Ayse Erdeniz, Emine Hafize Arga, Gul Yesil, Edanur Cakici, Ozlem Karbuz, Adem Sahbudak Bal, Zumrut Kara, Soner Sertan Ozer, Arife Metin Akcan, Ozge Elmas Bozdemir, Sefika Anil, Ayse Berna Uygun, Hatice Kilic, Omer Hancerli Torun, Selda Umit, Zuhal Sutcu, Murat Ozgokce Ozmen, Berfin Karaoglu Asrak, Hatice Alkan, Gulsum Kara Aksay, Ahu Ugur, Cuneyt Birbilen, Ahmet Ziya Bursal Duramaz, Burcu Akyuz Ozkan, Esra Burakay, Ozgur Yildirim Arslan, Sema Karadag Oncel, Eda Celik, Serkan Fazli Kilic, Ahmet Osman Ozen, Seval Sarikaya, Remzi Demirkol, Demet Arslan, Gazi Turel, Ozden Sert, Ahmet Sari, Ergul Orbak, Zerrin Sahin, Irfan Oguz Varan, Celal Akturk, Hacer Tuter Oz, Sadiye Kubra Durak, Fatih Oflaz, Mehmet Burhan Kara, Manolya Karpuz, Derya Talip Petmezci, Mey Hatipoglu, Nevin Oncel, Selim Turgut, Mehmet Elmali, Ferhan Somer, Ayper Kuyucu, Necdet Dinleyici, Ener Cagri Kurugöl, Zafer Ciftci, Ergin Kara, Ates |
author_sort | Yilmaz Ciftdogan, Dilek |
collection | PubMed |
description | Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9–12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 10(3)/μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217–0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244–5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298–0.559). Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD. |
format | Online Article Text |
id | pubmed-8819197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88191972022-02-07 COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group Yilmaz Ciftdogan, Dilek Ekemen Keles, Yildiz Cetin, Benhur Sirvan Dalgic Karabulut, Nazan Emiroglu, Melike Bagci, Zafer Buyukcam, Ayse Erdeniz, Emine Hafize Arga, Gul Yesil, Edanur Cakici, Ozlem Karbuz, Adem Sahbudak Bal, Zumrut Kara, Soner Sertan Ozer, Arife Metin Akcan, Ozge Elmas Bozdemir, Sefika Anil, Ayse Berna Uygun, Hatice Kilic, Omer Hancerli Torun, Selda Umit, Zuhal Sutcu, Murat Ozgokce Ozmen, Berfin Karaoglu Asrak, Hatice Alkan, Gulsum Kara Aksay, Ahu Ugur, Cuneyt Birbilen, Ahmet Ziya Bursal Duramaz, Burcu Akyuz Ozkan, Esra Burakay, Ozgur Yildirim Arslan, Sema Karadag Oncel, Eda Celik, Serkan Fazli Kilic, Ahmet Osman Ozen, Seval Sarikaya, Remzi Demirkol, Demet Arslan, Gazi Turel, Ozden Sert, Ahmet Sari, Ergul Orbak, Zerrin Sahin, Irfan Oguz Varan, Celal Akturk, Hacer Tuter Oz, Sadiye Kubra Durak, Fatih Oflaz, Mehmet Burhan Kara, Manolya Karpuz, Derya Talip Petmezci, Mey Hatipoglu, Nevin Oncel, Selim Turgut, Mehmet Elmali, Ferhan Somer, Ayper Kuyucu, Necdet Dinleyici, Ener Cagri Kurugöl, Zafer Ciftci, Ergin Kara, Ates Eur J Pediatr Original Article Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9–12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 10(3)/μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217–0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244–5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298–0.559). Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD. Springer Berlin Heidelberg 2022-02-07 2022 /pmc/articles/PMC8819197/ /pubmed/35129668 http://dx.doi.org/10.1007/s00431-022-04390-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Yilmaz Ciftdogan, Dilek Ekemen Keles, Yildiz Cetin, Benhur Sirvan Dalgic Karabulut, Nazan Emiroglu, Melike Bagci, Zafer Buyukcam, Ayse Erdeniz, Emine Hafize Arga, Gul Yesil, Edanur Cakici, Ozlem Karbuz, Adem Sahbudak Bal, Zumrut Kara, Soner Sertan Ozer, Arife Metin Akcan, Ozge Elmas Bozdemir, Sefika Anil, Ayse Berna Uygun, Hatice Kilic, Omer Hancerli Torun, Selda Umit, Zuhal Sutcu, Murat Ozgokce Ozmen, Berfin Karaoglu Asrak, Hatice Alkan, Gulsum Kara Aksay, Ahu Ugur, Cuneyt Birbilen, Ahmet Ziya Bursal Duramaz, Burcu Akyuz Ozkan, Esra Burakay, Ozgur Yildirim Arslan, Sema Karadag Oncel, Eda Celik, Serkan Fazli Kilic, Ahmet Osman Ozen, Seval Sarikaya, Remzi Demirkol, Demet Arslan, Gazi Turel, Ozden Sert, Ahmet Sari, Ergul Orbak, Zerrin Sahin, Irfan Oguz Varan, Celal Akturk, Hacer Tuter Oz, Sadiye Kubra Durak, Fatih Oflaz, Mehmet Burhan Kara, Manolya Karpuz, Derya Talip Petmezci, Mey Hatipoglu, Nevin Oncel, Selim Turgut, Mehmet Elmali, Ferhan Somer, Ayper Kuyucu, Necdet Dinleyici, Ener Cagri Kurugöl, Zafer Ciftci, Ergin Kara, Ates COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group |
title | COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group |
title_full | COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group |
title_fullStr | COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group |
title_full_unstemmed | COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group |
title_short | COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group |
title_sort | covid-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with kawasaki disease-turk mis-c study group |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819197/ https://www.ncbi.nlm.nih.gov/pubmed/35129668 http://dx.doi.org/10.1007/s00431-022-04390-2 |
work_keys_str_mv | AT yilmazciftdogandilek covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT ekemenkelesyildiz covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT cetinbenhursirvan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT dalgickarabulutnazan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT emiroglumelike covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT bagcizafer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT buyukcamayse covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT erdenizeminehafize covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT argagul covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT yesiledanur covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT cakiciozlem covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karbuzadem covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT sahbudakbalzumrut covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karasonersertan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT ozerarife covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT metinakcanozge covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT elmasbozdemirsefika covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT anilayseberna covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT uygunhatice covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT kilicomer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT hancerlitorunselda covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT umitzuhal covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT sutcumurat covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT ozgokceozmenberfin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karaogluasrakhatice covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT alkangulsum covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karaaksayahu covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT ugurcuneyt covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT birbilenahmetziya covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT bursalduramazburcu covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT akyuzozkanesra covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT burakayozgur covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT yildirimarslansema covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karadagonceleda covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT celikserkanfazli covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT kilicahmetosman covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT ozenseval covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT sarikayaremzi covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT demirkoldemet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT arslangazi covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT turelozden covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT sertahmet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT sariergul covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT orbakzerrin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT sahinirfanoguz covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT varancelal covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT akturkhacer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT tuterozsadiyekubra covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT durakfatih covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT oflazmehmetburhan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karamanolya covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karpuzderya covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT talippetmezcimey covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT hatipoglunevin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT oncelselim covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT turgutmehmet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT elmaliferhan covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT somerayper covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT kuyucunecdet covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT dinleyicienercagri covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT kurugolzafer covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT ciftciergin covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup AT karaates covid19associatedmultisystemicinflammatorysyndromein614childrenwithandwithoutoverlapwithkawasakidiseaseturkmiscstudygroup |